[
    [
        {
            "time": "",
            "original_text": "民生医药|专题】海外CXO公司年报梳理：跟随创新，新兴小分子及生物药业务驱动Lonza业绩持续增长",
            "features": {
                "keywords": [
                    "CXO公司",
                    "年报",
                    "创新",
                    "新兴小分子",
                    "生物药",
                    "Lonza",
                    "业绩持续增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "民生医药|专题】海外CXO公司年报梳理：跟随创新，新兴小分子及生物药业务驱动Lonza业绩持续增长",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 2
            }
        },
        {
            "time": "",
            "original_text": "民生医药|专题】IQVIA 2019年年报梳理：多元业务驱动，CRO全球龙头业绩稳定增长",
            "features": {
                "keywords": [
                    "IQVIA",
                    "2019年年报",
                    "多元业务",
                    "CRO",
                    "全球龙头",
                    "业绩稳定增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "民生医药|专题】IQVIA 2019年年报梳理：多元业务驱动，CRO全球龙头业绩稳定增长",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 1,
                "Headline_Structure": 6,
                "Source_Recency": 1
            }
        }
    ]
]